Sign in
CompletedNo phase

Journey™ UNI Post Market Clinical Follow-Up

Key facts

Who runs it
Smith & Nephew, Inc.
Where
Nashville, Park Ridge, and Scottsdale, United StatesSee the 3 sitesAlso in 1 other country, 1 site
Trial code
Status
Completed
People taking part
131 people enrolled
Started
11 Apr 2018
Ended
25 Jan 2024
Type of study
Observational
Treatments tested
  • Journey UNI Unicompartmental Knee System
Record updated
2 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Between 12 and 48 months previously, subject had unicompartmental knee replacement implanted for unicompartmental, NIDJD including OA, traumatic arthritis, avascular necrosis, for correction of functional deformity, or to repair a fracture that was unmanageable using other techniques
  • Subject received a JOURNEY UNI UKS implant (consisting of a femoral component, tibial baseplate, and a tibial insert)
  • Subject was considered skeletally mature at the time of surgery and was at least 18 years of age
  • Subject is willing to have retrospective data collected and to participate in required prospective follow-up visit(s) at the investigational site and to complete study procedures and questionnaires
  • Subject has consented to participate in the study by signing the Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent form (ICF)

Who cannot take part

  • Subject has Body Mass Index (BMI) > 40 within 1 month of surgery
  • Subjects who have received the Journey UNI UKS as part of a revision surgery
  • Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product in the past 30 days
  • Subject has a condition that may interfere with the unicompartmental knee arthroplasty (UKA) survival or outcome (e.g. Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease)
  • Subject has a known allergy to study device or one or more of its components
  • Subject, in the opinion of the Principal Investigator (PI), has an emotional or neurological condition that would preempt his/her ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse
  • Subject is known to be at risk for loss to follow-up, or failure to return for scheduled visits

Where in United States

Also in 1 other country, 1 site

  • Tennessee Orthopedic Alliance, P.A.Nashville, United States
  • Illinois Bone and Joint InstitutePark Ridge, United States
  • Orthopaedic Specialists of Central Arizona-ScottsdaleScottsdale, United States

About the trial

What the trial wants to find out

This is a retrospective/prospective, open-label single cohort, multicenter study to collect relevant clinical data from subjects with unicompartmental degeneration of the knee in whom the Journey UNI UKS was previously implanted.

The group in the trial

  • Journey™ UNI Unicompartmental Knee System

    Subjects previously received knee replacement

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Follow-Up of Subjects With a Journey™ UNI Unicompartmental Knee System Implant
Record updated
2 November 2026